DAEWON PHARMACEUTICAL CO.,LTD
003220 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003220001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 성동구 천호대로 386 대원제약, 서울특별시
- Website:
- https://www.daewonpharm.com/eng
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
Regulatory Filings
[기재정정]투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 신청)
|
Korean | 24.0 KB | ||
| 2025-09-09 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 19.3 KB | ||
| 2025-09-09 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 6.0 KB | ||
| 2025-09-02 00:00 |
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
|
Korean | 34.4 KB | ||
| 2025-09-02 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 31.4 KB | ||
| 2025-08-29 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 16.5 KB | ||
| 2025-08-25 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 13.7 KB | ||
| 2025-08-19 00:00 |
Share Issue/Capital Change
[기재정정]감자결정(종속회사의주요경영사항)
|
Korean | 20.0 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 2.7 MB | ||
| 2025-08-12 00:00 |
Share Issue/Capital Change
감자결정(종속회사의주요경영사항)
|
Korean | 16.1 KB | ||
| 2025-06-02 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 946.4 KB | ||
| 2025-05-30 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 신청)
|
Korean | 10.9 KB | ||
| 2025-05-23 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 13.2 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.3 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (DW4421 제3상 임상시험계획 승인신청(미란성))
|
Korean | 8.4 KB |
Automate Your Workflow. Get a real-time feed of all DAEWON PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DAEWON PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAEWON PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
United States of America
EPIX
United States of America
EPIX
Clinical-stage biopharma developing ARTEMIS® T-cell therapies for cancer & autoimmune disease.
United States of America
ESLA
United States of America
ESLA
Develops and commercializes innovative treatments for rare pediatric diseases.
United States of America
ETON
United States of America
ETON
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea
206650
South Korea
206650
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
United States of America
EPRX
United States of America
EPRX
A SPAC acquiring European biomanufacturers to create a large-scale CDMO for advanced therapies.
France
KINGS
France
KINGS
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France
EAPI
France
EAPI
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France
ALERS
France
ALERS
Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.
Sweden
EURI B
Sweden
EURI B
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
South Korea
263050